financetom
COR
financetom
/
Healthcare
/
COR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
CencoraCOR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Cencora, Inc. sources and distributes pharmaceutical products.

The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.

This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.

Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry.

The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023.

Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Latest News >
Medical Properties Trust Prioritizes California Investments in Prospect Medical Group Chapter 11
Medical Properties Trust Prioritizes California Investments in Prospect Medical Group Chapter 11
Jan 13, 2025
05:01 AM EST, 01/13/2025 (MT Newswires) -- Medical Properties Trust ( MPW ) said Sunday that it is prioritizing the protection of its investments in Prospect Medical Group's California hospitals as Prospect commences Chapter 11 bankruptcy restructuring. While Prospect's California facilities have reported volume growth and improved coverage trends in 2024, its overall liquidity has been adversely impacted by stalled...
AirBaltic IPO could be pushed back until early 2026, CEO says
AirBaltic IPO could be pushed back until early 2026, CEO says
Jan 13, 2025
DUBLIN, Jan 13 (Reuters) - AirBaltic's initial public offering (IPO) could be pushed back until early 2026, the Latvian airline's chief executive said on Monday. CEO Martin Gauss said the airline was still looking for a pre-IPO strategic investor ahead of the offering that was initially planned for last year. ...
Molecular Partners Expands Clinical Collaboration With Orano Med to Add 6 Targeted Alpha Radio-Therapies for Cancer
Molecular Partners Expands Clinical Collaboration With Orano Med to Add 6 Targeted Alpha Radio-Therapies for Cancer
Jan 13, 2025
05:26 AM EST, 01/13/2025 (MT Newswires) -- Molecular Partners AG ( MOLN ) expanded its strategic collaboration with Orano Med to include the development of an additional six targeted alpha radio-therapies for cancer, the companies said Sunday. The companies entered into an initial agreement in January 2024 to co-develop four programs. Under the expanded collaboration, Molecular Partners ( MOLN )...
Biden admin delays enforcement of order blocking Nippon Steel, US Steel deal, companies say
Biden admin delays enforcement of order blocking Nippon Steel, US Steel deal, companies say
Jan 13, 2025
WASHINGTON (Reuters) -The Biden administration delayed until June an order for Nippon Steel to abandon its $14.9 billion bid for U.S. Steel, the companies said on Saturday, giving them some time to revive the politically contentious deal. President Joe Biden blocked the acquisition on national security grounds on Jan. 3, and Treasury Secretary Janet Yellen said this week the proposed...
Copyright 2023-2025 - www.financetom.com All Rights Reserved